Stratec SE (ETR:SBS – Get Free Report)’s share price rose 1.1% during trading on Monday . The stock traded as high as €19.58 and last traded at €19.50. Approximately 21,075 shares traded hands during mid-day trading, an increase of 237% from the average daily volume of 6,253 shares. The stock had previously closed at €19.28.
Stratec Stock Performance
The firm has a market cap of $234.27 million, a PE ratio of 23.40, a price-to-earnings-growth ratio of 10.43 and a beta of 0.74. The business has a 50 day simple moving average of €21.69 and a two-hundred day simple moving average of €23.93. The company has a quick ratio of 1.65, a current ratio of 4.19 and a debt-to-equity ratio of 55.08.
About Stratec
Stratec SE, together with its subsidiaries, designs and manufactures automation and instrumentation solutions in the fields of in-vitro diagnostics and life sciences in Germany, European Union, and internationally. It designs and manufactures automated analyzer systems for clinical diagnostics and biotechnology customers; and offers complex consumables for diagnostics and medical applications. The company was formerly known as STRATEC Biomedical AG and changed its name to Stratec SE in December 2018.
Read More
- Five stocks we like better than Stratec
- The gold chart Wall Street is terrified of…
- What a Former CIA Agent Knows About the Coming Collapse
- Elon Musk already made me a “wealthy man”
- Buffett, Gates and Bezos Quietly Dumping Stocks—Here’s Why
- 1,500 Banks Just Handed the Fed Your Bank Account
Receive News & Ratings for Stratec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stratec and related companies with MarketBeat.com's FREE daily email newsletter.
